ATHE vs BIIB: Which Stock is Better?

Side-by-side comparison of Alterity Therapeutics Ltd and Biogen Inc in 2026

Comparison Updated:

ATHE

Alterity Therapeutics Ltd

$3.30

BIIB

Biogen Inc

$165.38

Key Metrics Comparison

MetricATHEBIIBWinner
Market Cap$59.81M$24.26BBIIB
P/E RatioN/A15.09BIIB
EPS (TTM)$N/A$10.96BIIB
Revenue Growth0.8%0.0%ATHE
Gross Margin97.7%76.6%ATHE

Analyze ATHE

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ATHE or BIIB a better investment?

Comparing ATHE and BIIB: Alterity Therapeutics Ltd has a market cap of $59.81M while Biogen Inc has $24.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ATHE and BIIB?

ATHE (Alterity Therapeutics Ltd) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ATHE or BIIB?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ATHE or BIIB?

ATHE has higher revenue growth at 0.8% vs 0.0% for BIIB.

Which company is more profitable: ATHE or BIIB?

Alterity Therapeutics Ltd (ATHE) has higher gross margins at 97.7% compared to 76.6% for BIIB.

Which is the larger company: ATHE or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $24.26B compared to $59.81M for ATHE.

Should I buy ATHE or BIIB in 2026?

Both ATHE and BIIB have investment merit. ATHE trades at $3.30 while BIIB trades at $165.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ATHE and BIIB stock?

Key differences: Market Cap ($59.81M vs $24.26B), P/E Ratio (N/A vs 15.1x), Revenue Growth (0.8% vs 0.0%), Gross Margin (97.7% vs 76.6%).

Popular Stock Comparisons